首页> 美国卫生研究院文献>World Journal of Gastroenterology >Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: A meta-analysis
【2h】

Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: A meta-analysis

机译:内镜下静脉曲张结扎术与内镜下硬化剂治疗食管静脉曲张破裂出血的Meta分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To compare the effect of endoscopic variceal ligation (EVL) with that of endoscopic injection sclerotherapy (EIS) in the treatment of patients with esophageal variceal bleeding.METHODS: We performed a systematic literature search of multiple online electronic databases. Meta-analysis was conducted to evaluate risk ratio (RR) and 95% confidence interval (CI) of combined studies for the treatment of patients with esophageal variceal bleeding between EVL and EIS.RESULTS: Fourteen studies comprising 1236 patients were included in the meta-analysis. The rebleeding rate in actively bleeding varices patients in the EVL group was significantly lower than that in the EIS group (RR = 0.68, 95%CI: 0.57-0.81). The variceal eradication rate in actively bleeding varices patients in the EVL group was significantly higher than that in the EIS group (RR = 1.06, 95%CI: 1.01-1.12). There was no significant difference about mortality rate between the EVL group and EIS group (RR = 0.95, 95%CI: 0.77-1.17). The rate of complications in actively bleeding varices patients in the EVL group was significantly lower than that in the EIS group (RR = 0.28, 95%CI: 0.13-0.58).CONCLUSION: Our meta-analysis has found that EVL is better than EIS in terms of the lower rates of rebleeding, complications, and the higher rate of variceal eradication. Therefore, EVL is the first choice for esophageal variceal bleeding.
机译:目的:为了比较内镜下静脉曲张结扎术(EVL)和内镜下注射硬化疗法(EIS)在食管静脉曲张破裂出血治疗中的作用。方法:我们对多个在线电子数据库进行了系统的文献检索。荟萃分析评估了合并研究治疗EVL和EIS之间食管静脉曲张破裂出血的风险比(RR)和95%置信区间(CI)。结果:荟萃研究包括14项研究,包括1236例患者。分析。 EVL组活动性静脉曲张患者的再出血率显着低于EIS组(RR = 0.68,95%CI:0.57-0.81)。 EVL组活动性静脉曲张患者的静脉曲张根除率显着高于EIS组(RR = 1.06,95%CI:1.01-1.12)。 EVL组和EIS组之间的死亡率没有显着差异(RR = 0.95,95%CI:0.77-1.17)。 EVL组活动性静脉曲张破裂出血患者的并发症发生率明显低于EIS组(RR = 0.28,95%CI:0.13-0.58)。结论:我们的荟萃分析发现EVL优于EIS。在再出血率,并发症发生率和根除静脉曲张率较高方面。因此,EVL是食管静脉曲张破裂出血的首选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号